[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,077,286
  • Shares Outstanding, K 172,642
  • Annual Sales, $ 291,850 K
  • Annual Income, $ 550 K
  • EBIT $ 47 M
  • EBITDA $ 63 M
  • 60-Month Beta 0.85
  • Price/Sales 3.77
  • Price/Cash Flow 63.69
  • Price/Book 84.65

Options Overview Details

View History
  • Implied Volatility 87.64% (-4.33%)
  • Historical Volatility 40.16%
  • IV Percentile 57%
  • IV Rank 18.32%
  • IV High 267.97% on 03/27/26
  • IV Low 47.20% on 09/17/25
  • Expected Move (DTE 32) 1.71 (27.38%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 499
  • Volume Avg (30-Day) 459
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 21,911
  • Open Int (30-Day) 20,697
  • Expected Range 4.53 to 7.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.03
  • Number of Estimates 4
  • High Estimate $0.05
  • Low Estimate $0.01
  • Prior Year $-0.01
  • Growth Rate Est. (year over year) +400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.83 +7.03%
on 04/22/26
7.01 -10.92%
on 05/07/26
+0.04 (+0.65%)
since 04/15/26
3-Month
5.25 +18.86%
on 03/25/26
7.12 -12.36%
on 03/02/26
-0.58 (-8.50%)
since 02/13/26
52-Week
4.30 +45.12%
on 06/13/25
10.08 -38.10%
on 11/05/25
+1.45 (+30.27%)
since 05/15/25

Most Recent Stories

More News
Xeris Biopharma Q1 Earnings Call Highlights

Xeris Biopharma (NASDAQ:XERS) reported a sharp increase in first-quarter 2026 revenue and raised the low end of its full-year revenue outlook, citing strong demand for RECORLEV and continued execution...

XERS : 6.24 (-2.19%)
Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma: Q1 Earnings Snapshot

XERS : 6.24 (-2.19%)
Xeris Biopharma Reports First Quarter 2026 Financial Results

Total product revenue increased 43% year-over-year to over $82 million Recorlev net revenue increased 95% year-over-year to $50 million ...

XERS : 6.24 (-2.19%)
Xeris Biopharma's Recorlev Momentum Looks Clear Until You Check the Guidance Math

Barchart Research What to Expect from XERS Earnings XERS Generated May 6, 2026 Current Price $6.37 EPS Estimate $$0.00 Consensus Rating Strong Buy Average Move 8.02% Xeris Biopharma's Recorlev Momentum...

XERS : 6.24 (-2.19%)
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

Conference Call to be Held at 8:30 a.m. ET

XERS : 6.24 (-2.19%)
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies,...

XERS : 6.24 (-2.19%)
Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma: Q4 Earnings Snapshot

XERS : 6.24 (-2.19%)
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance

Achieved record quarterly and full-year total revenue of $86 million and $292 million, respectively Provides full year 2026 total revenue guidance range of $375 million to $390 million ...

XERS : 6.24 (-2.19%)
Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit

Four Orange Book Listed Patents through March 2040 Orphan Drug Exclusivity through December 2028

XERS : 6.24 (-2.19%)
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026

Conference Call to be Held at 8:30 a.m. ET

XERS : 6.24 (-2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Xeris Biopharma Holdings is a biopharmaceutical company. It involved in developing and commercializing therapies for patient in endocrinology, neurology and gastroenterology. The company's principal product includes Gvoke(R), a ready-to-use liquid glucagon for the treatment of severe hypoglycemia and...

See More

Key Turning Points

3rd Resistance Point 6.52
2nd Resistance Point 6.46
1st Resistance Point 6.35
Last Price 6.24
1st Support Level 6.18
2nd Support Level 6.13
3rd Support Level 6.02

See More

52-Week High 10.08
Fibonacci 61.8% 7.87
Fibonacci 50% 7.19
Fibonacci 38.2% 6.51
Last Price 6.24
52-Week Low 4.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.